Arkolith/Insider Trading/INBS/Form 4

Sakiris Spiro Kevin

Chief Financial OfficerINTELLIGENT BIO SOLUTIONS INC. (INBS) · full profile →Form 4 · filed Dec 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2022Buy(P)48K$0.13$6K48K
Dec 22, 2022Buy(P)16K$0.87$14K16K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-036385) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML